Life Sciences

The U.S. Food and Drug Administration has approved a new drug made by Sunovion Pharmaceuticals to reduce seizures associated with epilepsy.

Revenue soared and losses narrowed at HeartWave International of Framingham due to rising sales of its Ventricular Assist System.

Karyopharm Therapeutics, a Natick-based clinical-stage pharmaceutical startup, has raised $108.8 million through an initial public offering of stock Wednesday.

Holliston-based Harvard Bioscience completed the spinoff of the regenerative medical device portion of its company last week, the company said.

Boston Scientific has completed its acquisition of a division of the Lowell-based electrophysiology business of C.R. Bard, which the Natick-based medical device manufacturer said could significantly boost its capabilities in the fast-growing market for advanced electrophysiology procedures.

The U.S. Food and Drug Administration has asked Marlborough-based Sunovion Pharmaceuticals Inc. to stop distributing promotional brochures for respiratory drug Brovana that it considers deceptive, according to a letter released Tuesday.

Sales and profits surged at Psychemedics Corp. of Acton in the third quarter.

A day after it said it would cut up to 1,500 jobs over the next two years, and on the same day it announced a third-quarter loss of $5 million, Boston Scientific said its chief financial officer will leave after the end of the year.

Boston Scientific plans to eliminate 1,100 to 1,500 positions worldwide over the next two years, the Natick-based medical device company announced Wednesday.

The first of 6,400 lawsuits against Boston Scientific (BSX) regarding the Natick-based company's transvaginal mesh devices will go to trial March 10, a lower-court judge ruled last week.